Influenza-associated hospitalization rates by underlying conditions, 2016-17 to 2019-20: a retrospective cohort study 2025

Influenza vaccine effectiveness against influenza A-associated emergency department, urgent care, and hospitalization encounters among US adults, 2022-2023 2024

Reduced likelihood of hospitalization with the JN.1 or HV.1 severe acute respiratory syndrome coronavirus 2 variants compared with the EG.5 variant 2024

Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance 2023

Protection of two and three mRNA vaccine doses against severe outcomes among adults hospitalized with COVID-19--VISION Network, August 2021 to March 2022 2023

Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network 2023

Incidence and predictors of abnormal anal cytology findings among HIV-infected adults receiving contemporary antiretroviral therapy 2016

Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States 2010

Syndromic surveillance for measleslike illnesses in a managed care setting 2004

Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans 2001

Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study 2001